IMMUNOTECH-B: VOLUNTARY ANNOUNCEMENTCAR-T-19 INJECTION WAS GRANTED BREAKTHROUGHTHERAPY DESIGNATION
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
IMMUNOTECH-B: RESIGNATION OF JOINT COMPANY SECRETARY AND CHANGE OF AUTHORISED REPRESENTATIVE
IMMUNOTECH-B: UPDATE ON CONTRACTUAL ARRANGEMENTS
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
IMMUNOTECH-B: 2024 INTERIM REPORT
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
IMMUNOTECH-B: ANNOUNCEMENT OF THE INTERIM RESULTSFOR THE SIX MONTHS ENDED 30 JUNE 2024
IMMUNOTECH-B: DATE OF BOARD MEETING
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
IMMUNOTECH-B: RESIGNATION OF CHIEF FINANCIAL OFFICER,COMPANY SECRETARY AND AUTHORISED REPRESENTATIVEANDAPPOINTMENT OF JOINT COMPANY SECRETARIES ANDAUTHORISED REPRESENTATIVE ANDWAIVER FROM STRICT COMPLIANCEWITH RULES 3.28 AND 8.17 OF THE LISTING RULES
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
IMMUNOTECH-B: DISCLOSEABLE TRANSACTIONDISPOSAL OF THE CERTIFICATES OF DEPOSITS
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
IMMUNOTECH-B: FOURTH AMENDED AND RESTATEDMEMORANDUM AND ARTICLES OF ASSOCIATION
IMMUNOTECH-B: POLL RESULTS OF THE ANNUAL GENERAL MEETINGHELD ON 24 MAY 2024
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
IMMUNOTECH-B: FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON 24 MAY 2024
IMMUNOTECH-B: NOTICE OF ANNUAL GENERAL MEETING